Tag Archives: Orchard Therapeutics PLC

US IPOs not done yet for 2018 as two foreigners pick Nasdaq for their maiden launch.

The News: Last week, Taiwan Liposome Co. Ltd. (TLC), which is developing lipid formulations of approved drugs for pain and eye disease, raised $22 million by offering 3.75 million ADSs… Read more »

October wraps up healthcare IPOs with another strong week as 2018 biotech explosion still on record pace.

The News: The Wall Street Journal reports that the pace of biotech IPOs in on track for a near-record year, although many are riskier due to being in earlier stages of development…. Read more »